NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,564,962 | +52.6% | 14,700 | +38.7% | 0.18% | +82.7% |
| Q1 2024 | $1,025,338 | -33.6% | 10,600 | -36.9% | 0.10% | -48.7% |
| Q1 2023 | $1,544,956 | -53.5% | 16,793 | -54.1% | 0.19% | -60.6% |
| Q4 2022 | $3,319,717 | +61.8% | 36,593 | +35.6% | 0.48% | +16.6% |
| Q3 2022 | $2,052,000 | +40.7% | 26,993 | +62.4% | 0.42% | +90.8% |
| Q1 2022 | $1,458,000 | +132.5% | 16,617 | +130.4% | 0.22% | +42.5% |
| Q3 2020 | $627,000 | -5.4% | 7,213 | +3.1% | 0.15% | +35.4% |
| Q4 2019 | $663,000 | -72.4% | 6,998 | -74.6% | 0.11% | -75.1% |
| Q3 2019 | $2,398,000 | +395.5% | 27,598 | +420.9% | 0.45% | +354.0% |
| Q2 2019 | $484,000 | +25.4% | 5,298 | +17.7% | 0.10% | +26.6% |
| Q4 2018 | $386,000 | -52.8% | 4,500 | -58.4% | 0.08% | -57.1% |
| Q2 2018 | $817,000 | -52.4% | 10,812 | -49.1% | 0.18% | -57.8% |
| Q1 2018 | $1,716,000 | +52.3% | 21,227 | +61.7% | 0.44% | +62.1% |
| Q3 2017 | $1,127,000 | +235.4% | 13,127 | +226.0% | 0.27% | +116.9% |
| Q2 2017 | $336,000 | – | 4,027 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 318,637 | $27,960,000 | 7.08% |
| MANAGED ASSET PORTFOLIOS, LLC | 417,183 | $36,608,000 | 5.02% |
| SAL Trading, LLC | 233,600 | $20,498,000 | 4.77% |
| SCHARF INVESTMENTS, LLC | 1,340,680 | $117,662,000 | 3.49% |
| SAL Trading, LLC | 155,783 | $13,670,000 | 3.18% |
| First Fiduciary Investment Counsel, Inc. | 169,371 | $14,862,000 | 2.90% |
| PRENTISS SMITH & CO INC | 55,026 | $4,829,000 | 2.90% |
| GARLAND CAPITAL MANAGEMENT INC | 47,630 | $4,180,000 | 2.77% |
| Cullen Capital Management, LLC | 3,295,271 | $289,160,000 | 2.66% |
| WILKINS INVESTMENT COUNSEL INC | 133,880 | $11,748,000 | 2.65% |